ICR opens new phase I unit in Dallas-Fort Worth area

Wednesday, June 20, 2012 11:49 AM

Independent Clinical Research (ICR) has opened the doors to its two state-of-the-art phase I facilities in the Dallas-Fort Worth area.

The new facilities offers sponsors and CROs two options: a 12-bed facility for small-scale studies or a hospital-based unit with 90+ beds for large-scale studies.

“Today as doctors, we have more treatment options than ever before, but we still need more of these medications. To develop these new medications we are obligated to conduct clinical trials,” said Dr. Khalid Mahmood, president and CEO of ICR. “ICR is excited to play a role in early-stage clinical trials so new drugs and devices can quickly gain FDA approval.

ICR, which has been conducting clinical trials for over 7 years in the Dallas-Fort Worth area, has a highly experienced phase I clinical team that consists of a group of research physicians to serve as Investigators, with each one being a leading expert in their respective therapeutic area.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 21

As job growth in drug development sector soars, more employees are seeking new opportunities

U.K. study: Prisoners should have the right to participatein clinical trials on moral grounds, for healthcare access

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs